drugset / Trial / NCT01725620
Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®
RandomizedCrossoverDouble-blindTreatment
Summary
To compare the pharmacokinetic characteristic of LBEC0101 25mg with active comparator, Enbrel® 25mg.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 25 mg | Subcutaneous |
| Subject | LBEC0101 | Protein / enzyme biologic | 25 mg | Subcutaneous |
Indications
No indication recorded.